Skip to main content

Table 1 Methodological differences between AusDiab and DRUID studies

From: High rates of albuminuria but not of low eGFR in Urban Indigenous Australians: the DRUID Study

Measure

AusDiab

DRUID

Blood Pressure

Dinamap semi-automatic oscillometric recorder

Welch Allyn Spot Vital signs monitor

HbA1c*

Boronate affinity high-performance liquid chromatography (BioRad Variant Haemoglobin Testing System, BioRad, Hercules, CA, USA)

Percentage of total haemoglobin after separation by ion-exchange chromatography on a Pharmacia Mono-S column (results traceable to DCCT method)

Serum creatinine

Modified Jaffe reaction (Olympus AU600 auto-analyser)**

Kinetic Jaffe (Hitachi 917)

eGFR

Estimated from calibrated serum creatinine values, using the "175" MDRD equation

Estimated from pre-IDMS creatinine values, using "186" MDRD equation

Urine albumin

Immunonephelometry (Beckman Array)

Immunonephelometry (Beckman array 360)

Urine creatinine

Modified Jaffe reaction (Olympus AU600 auto-analyser)

Kinetic Jaffe (Hitachi 917)

CRP

Data unavailable, therefore CRP not included in comparative model

 
  1. * Comparison of 53 samples by both HbA1c methods: mean HbA1c 5.94% (Pharmacia) vs 6.33% (BioRad), r = 0.972, p < 0.001, Bland-Altman mean difference 0.396 (95%CI 0.309-0.483), p = 0.027 (Pitman's).
  2. **subsequent calibration to IDMS method by re-assaying a stored sub sample (n = 241)